Citation: Rh. Vonderheide, From cancer genomics to cancer immunotherapy: toward second-generation tumor antigens (vol 22, pg 516, 2001), TRENDS IMMU, 22(10), 2001, pp. 581-581
Citation: Rh. Vonderheide et al., Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase, CLIN CANC R, 7(11), 2001, pp. 3343-3348
Authors:
Vonderheide, RH
Butler, MO
Liu, JF
Battle, TE
Hirano, N
Gribben, JG
Frank, DA
Schultze, JL
Nadler, LM
Citation: Rh. Vonderheide et al., CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity, INT J ONCOL, 19(4), 2001, pp. 791-798
Authors:
Vonderheide, RH
Schultze, JL
Anderson, KS
Maecker, B
Butler, MO
Xia, ZN
Kuroda, MJ
von Bergwelt-Baildon, MS
Bedor, MM
Hoar, KM
Schnipper, DR
Brooks, MW
Letvin, NL
Stephans, KF
Wucherpfennig, KW
Hahn, WC
Nadler, LM
Citation: Rh. Vonderheide et al., Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals, CANCER RES, 61(23), 2001, pp. 8366-8370
Authors:
Trojan, A
Witzens, M
Schultze, JL
Vonderheide, RH
Harig, S
Krackhardt, AM
Stahel, RA
Gribben, JG
Citation: A. Trojan et al., Generation of cytotoxic T lymphocytes against native and altered peptides of human leukocyte antigen-A0201 restricted epitopes from the human epithelial cell adhesion molecule, CANCER RES, 61(12), 2001, pp. 4761-4765
Citation: Md. Kraus et al., The spleen as a diagnostic specimen - A review of 10 years' experience at two tertiary care institutions, CANCER, 91(11), 2001, pp. 2001-2009
Authors:
Trojan, A
Schultze, JL
Witzens, M
Vonderheide, RH
Ladetto, M
Donovan, JW
Gribben, JG
Citation: A. Trojan et al., Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies, NAT MED, 6(6), 2000, pp. 667-672
Citation: Rh. Vonderheide et al., The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes, IMMUNITY, 10(6), 1999, pp. 673-679